Peter Walker’s Post

View profile for Peter Walker
Peter Walker Peter Walker is an Influencer

Head of Insights @ Carta | Data Storyteller

Founders - use our current benchmark data to help raise your next VC round. Broken out into 25th, 50th, and 75th percentiles so you can place your fundraise within the broad current market. 𝗩𝗮𝗹𝘂𝗮𝘁𝗶𝗼𝗻𝘀 • All numbers in the chart below are post-money valuations for primary rounds in Q3 2024. • Solid growth in Seed and Series A valuations from Q2. 𝗖𝗮𝘀𝗵 𝗥𝗮𝗶𝘀𝗲𝗱 • All numbers reflect the total amount raised in a given round. • Rounds have gotten larger at the 50th pct over the past year. 𝗗𝗶𝗹𝘂𝘁𝗶𝗼𝗻 • Percentages in the chart reflect the total equity sold to investors in the round. For SAFE rounds, it reflects the expected ownership at conversion given the valuation cap. • Dilution is calculated for each round independently - so you can't just read across the median valuation and round size to get the dilution figure! Other people will have different definitions of "pre-seed" - I get it! Amount raised in a SAFE round is the biggest determinant of the valuation cap. Also good to note that some of the pre-seed raises will probably end up raising more money on the same valuation cap. That part of the market is tricky. 𝗞𝗲𝘆 𝘁𝗵𝗶𝗻𝗴𝘀 𝘁𝗼 𝗸𝗻𝗼𝘄 𝗮𝗯𝗼𝘂𝘁 𝗤𝟯 1. Okay quarter. $20B invested into Carta startups, little less than Q2, little more than Q1. 2. Down rounds still hovering around 20% of all rounds. Still more kludge to work through from the boom times. 3. Dilution continues to center around 20% in Seed and Series A. 4. Time between rounds notched down for Seed to A, but up for A to B. Still good to plan for longer than you expect. 5. M&A bounceback? 170 companies acquired last quarter, the highest since 2022. Our full State of Private Markets report for Q3 is now live. Link in comments for the full report. If you want this graphic for your industry, give me shout that out in the comments below. Here's to a strong fundraising close & a better 2025! If you’d like more of our data in your inbox, subscribe today: https://lnkd.in/gNa_Dk-F

  • No alternative text description for this image
Camilo Parra

CEO @ HelloWellness: The natural way to reduce high blood pressure so you can get off your meds | Managing Partner @ BrainPower: DTC growth agency for Amazon and retail consumer brands

4mo

Thank you Peter! Do you have insights for the health tech industry?

Kelvin Mu

Early Stage Investor @ Translink Capital

4mo

Hi Peter Walker thanks for sharing - super helpful.. Do you have this by different industries as well? healthcare, AI, etc.

Peter Walker thanks for spreading the good (benchmark) word! Too often founder have unrealistic, off market expectations. It why we also publish our own benchmarking for Consumer startups.

Charles Bourbonnais

CEO at Hive-Zox - Real-Time Data Intelligence for Logistics & Supply Chains

4mo

Peter, would you happen to have this same chart for European Startups?

Hey Peter, as always, thanks for the super-useful data. Do you have the biotech data without life sciences? I feel they are two very different worlds once you factor regulatory approval into the numbers...

Anu Sharma

Building better maternity care for all

4mo

Peter Walker strong work as always! Would love a breakout for healthcare (tech enabled services vs SaaS/AI).

Damian Miller

Executive | Advisor | Entrepreneur

4mo

I put this right into the appendix of the deck, it helps build alignment and shifts the focus back to building a great venture

Ali R Rahimi, MD MPH

CEO and Founder @ ALYKA Health | Cardiovascular Medicine and Public Health

4mo

Peter Walker nice insights. What is the data for SaaS digital health start-ups? Thanks

Jorian Hoover

Startup Fundraising Sparring Partner | Harvard MBA | $130M+ raised with founders

4mo

Peter Walker this data is the first place I send any founder who wants to understand what's "market terms" for fundraising. The key is the trade-off between amount raised and dilution, so that you have enough of the pie left for the later rounds.

Ryan Humphreys

Vice President of Growth at Cancer Insights | MBA, Board Member & Advisor

4mo

Those dilution numbers don’t look correct to me. How does a $1.3M raise on a cap of $14M result in a 19.6% dilution? Can anyone help with this?

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics